MedTrace Logo

Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health

NCT01890889 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2013-11-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of a food-source nutrient containing bitter orange by comparing changes 45 blood chemistries and self-reported quality of life.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ad-Chol-Pre

DIETARY_SUPPLEMENT

Half-dose Ad-Chol-Pre

OTHER

Defatted egg yolk without the active ingredient of the other two interventions

Sponsors & Collaborators

  • Integrative Health Technologies, Inc.

    lead NETWORK

Principal Investigators

  • Gilbert R Kaats, PhD FACN · Integrative Health Technologies, Inc.

  • Harry G Preuss, MD MACN · Georgetown University Medical Center, Dept of Biochemistry, Medicine and Pathology

  • Sidney J Stohs, PhD · Dean Emeritus, Creighton University Health Sciences Center

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-11-30
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01890889 on ClinicalTrials.gov